Loading...
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is considered to be a hepatic manifestation of metabolic syndrome, and its incidence is rapidly increasing worldwide. It is currently the most common chronic liver disease. NASH can progress to liver cirrhosis and hepatocel...
Saved in:
| Published in: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Baishideng Publishing Group Inc
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4385525/ https://ncbi.nlm.nih.gov/pubmed/25852263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i13.3777 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|